LC has been demonstrated to significantly downregulate expressions of the hepatic CES1 protein; the CES1 contents in CP-B patients and CP-C patients were decreased to 70% and 30% of those of healthy subjects, respectively, and the CES1 enzyme content in CP-A patients was comparable to that of healthy subjects [9]. This evidence concerns the gene CES1 and carotid plaque build.